Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017 (2017), Article ID 1465912, 9 pages
https://doi.org/10.1155/2017/1465912
Research Article

Chenodeoxycholic Acid Derivative HS-1200 Inhibits Hepatocarcinogenesis and Improves Liver Function in Diethylnitrosamine-Exposed Rats by Downregulating MTH1

1Department of Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250021, China
2Department of Gastroenterology, Jinan Hospital, Jinan, Shandong 250013, China
3Central Laboratory, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250021, China

Correspondence should be addressed to Chengyong Qin; moc.361@0002niqgnoygnehc

Received 6 September 2016; Accepted 9 January 2017; Published 5 February 2017

Academic Editor: Xin-Yuan Guan

Copyright © 2017 Miao Xu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Miao Xu, Qi Zhao, Donghui Shao, Hui Liu, Jianni Qi, and Chengyong Qin, “Chenodeoxycholic Acid Derivative HS-1200 Inhibits Hepatocarcinogenesis and Improves Liver Function in Diethylnitrosamine-Exposed Rats by Downregulating MTH1,” BioMed Research International, vol. 2017, Article ID 1465912, 9 pages, 2017. doi:10.1155/2017/1465912